Taiwan · Delayed Price · Currency is TWD TTY Biopharm Company Statistics
Total Valuation
TPEX:4105 has a market cap or net worth of TWD 19.69 billion. The enterprise value is 19.64 billion.
| Market Cap | 19.69B |
| Enterprise Value | 19.64B |
Important Dates
The next estimated earnings date is Friday, March 5, 2027.
| Earnings Date | Mar 5, 2027 |
| Ex-Dividend Date | Mar 26, 2026 |
Share Statistics
TPEX:4105 has 248.65 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 248.65M |
| Shares Outstanding | 248.65M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 11.09% |
| Owned by Institutions (%) | 12.00% |
| Float | 191.55M |
Valuation Ratios
The trailing PE ratio is 11.89 and the forward PE ratio is 10.74.
| PE Ratio | 11.89 |
| Forward PE | 10.74 |
| PS Ratio | 2.89 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | 12.38 |
| P/OCF Ratio | 11.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 12.34.
| EV / Earnings | 11.84 |
| EV / Sales | 2.88 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 9.16 |
| EV / FCF | 12.34 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.33 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.88 |
| Debt / FCF | 1.18 |
| Interest Coverage | 57.38 |
Financial Efficiency
Return on equity (ROE) is 22.52% and return on invested capital (ROIC) is 21.78%.
| Return on Equity (ROE) | 22.52% |
| Return on Assets (ROA) | 10.21% |
| Return on Invested Capital (ROIC) | 21.78% |
| Return on Capital Employed (ROCE) | 20.71% |
| Weighted Average Cost of Capital (WACC) | 4.40% |
| Revenue Per Employee | 19.91M |
| Profits Per Employee | 4.85M |
| Employee Count | 342 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, TPEX:4105 has paid 449.69 million in taxes.
| Income Tax | 449.69M |
| Effective Tax Rate | 19.99% |
Stock Price Statistics
The stock price has decreased by -1.12% in the last 52 weeks. The beta is 0.08, so TPEX:4105's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -1.12% |
| 50-Day Moving Average | 79.13 |
| 200-Day Moving Average | 78.08 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 872,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4105 had revenue of TWD 6.81 billion and earned 1.66 billion in profits. Earnings per share was 6.66.
| Revenue | 6.81B |
| Gross Profit | 3.95B |
| Operating Income | 1.94B |
| Pretax Income | 2.25B |
| Net Income | 1.66B |
| EBITDA | 2.15B |
| EBIT | 1.94B |
| Earnings Per Share (EPS) | 6.66 |
Balance Sheet
The company has 2.80 billion in cash and 1.88 billion in debt, with a net cash position of 917.18 million or 3.69 per share.
| Cash & Cash Equivalents | 2.80B |
| Total Debt | 1.88B |
| Net Cash | 917.18M |
| Net Cash Per Share | 3.69 |
| Equity (Book Value) | 8.33B |
| Book Value Per Share | 30.09 |
| Working Capital | 3.81B |
Cash Flow
In the last 12 months, operating cash flow was 1.72 billion and capital expenditures -126.32 million, giving a free cash flow of 1.59 billion.
| Operating Cash Flow | 1.72B |
| Capital Expenditures | -126.32M |
| Depreciation & Amortization | 202.35M |
| Net Borrowing | -159.15M |
| Free Cash Flow | 1.59B |
| FCF Per Share | 6.40 |
Margins
Gross margin is 58.02%, with operating and profit margins of 28.54% and 24.36%.
| Gross Margin | 58.02% |
| Operating Margin | 28.54% |
| Pretax Margin | 33.04% |
| Profit Margin | 24.36% |
| EBITDA Margin | 31.52% |
| EBIT Margin | 28.54% |
| FCF Margin | 23.37% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 5.68%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 5.68% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 69.09% |
| FCF Payout Ratio | 70.33% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 5.64% |
| Earnings Yield | 8.41% |
| FCF Yield | 8.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.
| Last Split Date | Aug 13, 2014 |
| Split Type | Forward |
| Split Ratio | 1.067 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |